Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension.

Annals of laboratory medicine - 1 May 2016

Kim Hyunjung, Park Joonhong, Chae Hyojin, Lee Gun Dong, Lee Sang Yoon, Lee Jong Min, Oh Yong Seog, Kim Myungshin, Kim Yonggoo

Abstract excerpt

BACKGROUND: Currently, the hypertension (HTN) patients undergo appropriate medical treatment, and traditional risk factors are highly controlled. Therefore, potential risk factors of atherosclerotic vascular diseases (AVD) and venous thromboembolisms (VTE) in HTN should be reconsidered. We investigated thrombophilic genetic mutations and existing biomarkers for AVD or VTE in HTN patients receiving treatment....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Factor V

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Fibrin Fibrinogen Degradation Products

Share to Homocysteine

Share to Platelet Count

Share to Prothrombin

Share to Vascular Diseases

Share to Venous Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 26915609
DOI: 10.3343/alm.2016.36.3.215
PMCID: PMC4773261

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension.PMID 26915609Read ↗

Update on genetic risk factors for thrombosis and atherosclerotic vascular disease.Semantic proximity Read ↗

Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and ThromboembolismSemantic proximity Read ↗

Non-genetic and genetic risk factors for adult cerebral venous thrombosis.Semantic proximity Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

Polymorphisms C677T and A1298C of MTHFR Gene: Homocysteine Levels and Prothrombotic Biomarkers in Coronary and Pulmonary Thromboembolic Disease.Semantic proximity Read ↗

Methylenetetrahydrofolate Reductase Gene Polymorphism (C677T) as a Risk Factor for Arterial Thrombosis in Georgian Patients.Semantic proximity Read ↗

Genetics of atherothrombosis and thrombophilia.Semantic proximity Read ↗

Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature.Semantic proximity Read ↗

Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia.Semantic proximity Read ↗

Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.Semantic proximity Read ↗

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension.Semantic proximity Read ↗

Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.